Merck
CN
HomeBetter, Faster, Safer Vaccine Production

Better, Faster, Safer Vaccine Production

LEARN HOW WE CAN TAKE YOUR INNOVATION from early phase development to full-scale GMP-manufacturing efficiently, safely, and cost-effectively

Contact us today to discuss your needs with a technical representative.

Fields indicated by an * are required.

Related Videos

Slide 1 of 6
Assuring Viral Safety: Better, Faster Virus Production
Assuring Viral Safety: Better, Faster Virus Production
Prevent, detect and remove bad viruses from your virus production.
Efficient DNA Clearance
Efficient DNA Clearance
Remove DNA from your virus production process.
Flexible Manufacturing
Flexible Manufacturing
Use flexible manufacturing strategies can help meet growing vaccine demand.
Intensified Virus Purification
Intensified Virus Purification
An intensified purification process can improve efficiency and productivity for virus production.
Virus Risk Mitigation in the Development of Biological Medicinal Products
Virus Risk Mitigation in the Development of Biological Medicinal Products
Learn about global regulatory requirements from the US FDA, WHO, European Pharmacopoeia and ICH.
LNP Animation Video
LNP Animation Video
mRNA and lipid nanoparticle delivery system

Featured Articles

We are committed to partnering with pharmaceutical companies, organizations and other companies to accelerate vaccine development and ultimately increase access globally. Our collaborations with worldwide vaccine developers and researchers include:

  • Leveraging previous efforts at an adenovirus-based vaccine platform for rapid development of a Covid-19 vaccine platform (read more)
  • Building on previous collaborations with the Baylor College of Medicine to optimize production of two Covid-19 vaccine candidates (read more)
  • Joining the DiViNe Consortium in Europe to address low yields and high costs of vaccine purification (read our white paper)
  • Developing optimized purification processes with the International Vaccine Institute (read more)
  • Receiving a grant from the Bill & Melinda Gates Foundation as part of a consortium pursuing a new manufacturing platform that would radically increase vaccine availability and affordability in developing countries (read more)

Contact us today to discuss your needs with a technical representative, and discover new solutions for better, faster, safer vaccine development.

Related Links

Natrix® Q Chromatography Membrane Adsorbers

A breakthrough in membrane chromatography

Read More...

Fractogel® Ion Exchange Chromatography Resins

For Reliable and Effective Protein Purification

Read More...

Benzonase®Endonuclease

Safety Plus Emprove® Expert
DNA and RNA Removal for downstream processing

Read More...

Emprove® Chemicals Portfolio

Confidently fast track your new drug to market

Read More...

Related Applications
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Virus-Based Vaccine Manufacturing
Manufacturing viral vaccines is complex and there is no templated approach. Each process must be tailored to the shape, size, nature, physico-chemical behavior, stability, and host specificity of the virus. Learn all about this core platform technology and how expertise—empowered by collaboration— can overcome manufacturing challenges.
Viral Vector Vaccine Manufacturing
A relatively templated manufacturing process can be used to produce live vector vaccines. Challenges exist, however, and include yield loss due to sterile filtration, vector aggregation and scaling adherent cultures. Learn all about this core platform technology and how expertise—empowered by collaboration— can overcome manufacturing challenges.
Plasmid DNA Vaccines Manufacturing
Manufacturing plasmid DNA (pDNA) vaccines is challenging due to low productivity of fermentation and the large size and negative charge of the plasmid. The lysate can also be highly viscous with contaminants similar to pDNA leading to low resolution separation. Learn all about this core platform technology and how expertise—empowered by collaboration— can overcome manufacturing challenges.
mRNA Vaccine Process Manufacturing
Development and manufacturing of mRNA vaccines is relatively simple, scalable and extremely rapid. A range of technologies are available to increase process productivity, maximize yield, recovery and impurity removal. Learn all about this new platform technology and how expertise—empowered by collaboration—can refine mRNA approaches.
Related Services
Emprove® Chemicals
To simplify raw material selection while satisfying regulatory requirements, our Emprove® Chemicals portfolio contains over 400 pharmaceutical raw materials offering the comprehensive, up-to-date documentation you need to navigate regulatory challenges, manage risks, and improve processes.
Cell Culture Media Stability and Testing Services
Our cell culture media stability and testing services can provide an assigned expiration date for custom products, or test for nutritional component data to optimize your bioprocess.
Emprove® Program
Emprove® Program: The smart way to master compliance and control. Complementing our product portfolio, the Emprove® Program provides convenient access to reliable technical, regulatory and supply information in Emprove® Dossiers to support your risk assessment continuum.
Related Product Categories
Excipients for Your Liquid Application
Whether you are developing solutions, emulsions or suspensions – we provide high-quality pharmaceutical excipients for liquid formulations.
Bioprocessing Mobius® Single-Use Bioreactors
The Mobius® Bioreactor family includes the bench scale (2 mL and 3 L), pilot, clinical and commercial manufacturing (50 – 2,000 L) single-use bioreactors that enable cell culturing capabilities from early process development through commercial batch production.
Bioprocessing Cell Culture Media
Our off-the-shelf and customizable bioprocessing cell culture media (CCM) products enhance productivity in upstream mAb, vaccine, gene/cell therapy processes.
Clarification Filter Holders and Systems for Bioprocessing
Our flexible hardware and systems for disposable depth filters are ideal for clarification at pilot and process scales, featuring the modular Pod device that enables scale-up and scale-down within the same footprint.
Downstream Process & Formulation Chemicals
Our broad portfolio of downstream chemicals simplifies raw material specification with optimized quality attributes for all your applications – while providing industry-leading support and documentation to help navigate regulatory challenges, manage risks, and improve processes.
Single-Use Mixers
Explore Mobius® single-use mixing solutions for pharmaceutical ingredient blending and process solution preparation.
Integrity Testers
Efficient Filter Integrity Testing: Elevate quality control with Integritest® 5, offering bubble point, diffusion, and hydrophobic testing in-line or offline.
Virus Inactivation
Enhance biopharma safety and compliance with our virus inactivation solutions, including pasteurization and low pH treatment.
Buffers & pH Adjusters
Our broad portfolio of buffer materials manufactured according to GMP guidelines includes excipients specifically for drug formulation and manufacturing, including high-risk applications. Whether your product is a small or large molecule drug, we offer high-quality buffers and pH adjusters with regulatory support.
Sterile Filters
Secure microbial safety with sterile filtration and disposable filters. Choose the right sterilizing filter for effective bioburden control.
登录以继续。

如要继续阅读，请登录或创建帐户。

暂无帐户？